Gene therapies hold immense promise for treating sight loss. These therapies use a modified, harmless virus to deliver ...

DELRAY BEACH, FL / ACCESS Newswire / August 12, 2025 / Adolore BioTherapeutics, Inc., ("Company" or "Adolore") announced that ...

“At ProBio, we recognize that every gene therapy program represents a critical opportunity to change lives,” said Allen Guo, ...

CRISPR Therapeutics’ CRSP Casgevy, a one-shot gene therapy, was approved in late 2023 and early 2024 across the United States ...

The use of artificial intelligence for batch monitoring and digital twin development are redefining process control — ...

DELRAY BEACH, FL / ACCESS Newswire / August 12, 2025 / Adolore BioTherapeutics, Inc., ("Company" or "Adolore") announced that Roy Clifford Levitt, MD, Clinical Professor at the University of Miami, Pr ...

Sartorius Stedim Biotech has agreed to invest $3m in Nanotein Technologies, a US-based company engaged in the development of ...

HIV-fighting antibodies produced in infant macaques in a preclinical trial could be the future of HIV prevention in humans, ...

A Food and Drug Administration official is getting his job back as the agency’s top vaccine regulator, less than two weeks ...

Vinay Prasad resumes leadership at the FDA’s CBER two weeks after he resigned amid cell and gene therapy controversy.

Surging demand for vectors has also prompted suppliers to explore novel transfection technologies—including electroporation or transposon-based systems—to improve yield. Traditional methods rely on ...

Sarepta’s troubles had nothing to do with Arrowhead’s assets, and yet both companies have seen their stock prices decline ...